Drug Pipeline
Delivering on the Promise of AI Drug Discovery
Through GALILEO™, we’ve discovered 192 compounds for 26 targets, validated with multiple world class academic and corporate laboratories.
// Validated with Leading Academic & Corporate Labs
-
Our infectious disease program is developing the next generation of antivirals that have broader activity and demonstrate best-in-class antiviral characteristics.
1 Lead Asset
10+ Targets
50+ Asset In Vitro Validation
* Previously studied in another indication, the drug demonstrated a favorable safety profile and was well tolerated
-
SARS-CoV-2, hCoV-α/hCoV-β estimated patient population. Over 775 million confirmed cases globally as of August 2024. (Source: https://data.who.int/dashboards/covid19/cases)
Hepatitis C Virus estimated patient population. Estimated 50 million people chronically infected globally. (Source: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c)
Norovirus estimated patient population. Estimated 685 million cases globally per year. (Source: https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/norovirus)
Influenza A & B estimated patient population. Estimated 1 billion cases of influenza globally per year. (Source: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal))
Hepatitis B Virus estimated patient population. Estimated 254 million people chronically infected globally. (Source: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b)
Epstein-Barr Virus estimated patient population. More than 7 billion, 90% of the global adult population is infected. (Source: https://www.ncbi.nlm.nih.gov/books/NBK559285)
-
Our Oncology program has discovered potential therapeutics for two broad spectrum oncology targets, AXL/BRD4.
1 Lead asset
2 Targets
20 Assets In Vitro Validation
* Previously studied in another indication, the drug demonstrated a favorable safety profile and was well tolerated
-
Thyroid Cancer estimated patient population. Estimated 586 thousand cases worldwide. (Source: Shank JB, Are C, Wenos CD. Thyroid Cancer: Global Burden and Trends. Indian J Surg Oncol. 2022;13(1):40-45. doi:10.1007/s13193-021-01429-y)
-
Our longevity program is focused on the growing evidence linking gastrointestinal dysmotility to numerous indications, including mental health, metabolism, and neurological disorders.
3 Targets
1 Asset In Vitro Validation
-
We recently launched a program and completed in-silico discovery work for compounds against multiple targets related to ANCA-Associated Vasculitis (AAV)
ANCA (anti-neutrophil cytoplasmic antibody)-associated vasculitis is a group of rare, life-threatening, immune disorders, which are characterized by a “necrotizing inflammatory process that predominantly affects small and medium-sized blood vessels” such as arterioles, capillaries, and venules.
There are three subtypes of AAV that include Granulomatosis with polyangiitis (GPA, previously Wegener’s disease), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, previously Churg-Strauss syndrome)
5 Targets
100+ Asset In Silico Validation
